The shape of low-concentration dose–response functions for benzene: implications for human health risk assessment

References

• Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. 2009. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer. 100:822–828.
   PubMed Web of Science ®Google Scholar
• Arnold SM, Angerer J, Boogaard PJ, Hughes MF, O'Lone RB, Robison SH, Schnatter AR. 2013. The use of biomonitoring data in exposure and human health risk assessment: benzene case study. Crit Rev Toxicol. 43:119–153.
   PubMed Web of Science ®Google Scholar
• Bauer AK, Faiola B, Abernethy DJ, Marchan R, Pluta LJ, Wong VA, Roberts K, Jaiswal AK, Gonzalez FJ, Butterworth BE, et al. 2003. Genetic susceptibility to benzene-induced toxicity: role of NADPH: quinone oxidoreductase-1. Cancer Res. 63:929–935.
   PubMed Web of Science ®Google Scholar
• Bechtold WE, Henderson RF. 1993. Biomarkers of human exposure to benzene. J Toxicol Environ Health. 40:377–386.
   PubMed Web of Science ®Google Scholar
• Bogen KT. 2019. Inflammation as a cancer co-initiator: new mechanistic model predicts low/negligible risk at noninflammatory carcinogen doses. Dose Response. 17:1559325819847834.
   Web of Science ®Google Scholar
• Campagna M, Satta G, Campo L, Flore V, Ibba A, Meloni M, Tocco MG, Avataneo G, Flore C, Fustinoni S, et al. 2012. Biological monitoring of low-level exposure to benzene. Med Lav. 103:338–346.
   PubMed Web of Science ®Google Scholar
• Carrieri M, Spatari G, Tranfo G, Sapienza D, Scapellato ML, Bartolucci GB, Manno M. 2018. Biological monitoring of low level exposure to benzene in an oil refinery: effect of modulating factors. Toxicol Lett.
   PubMed Web of Science ®Google Scholar
• Carbonari D, Chiarella P, Mansi A, Pigini D, Iavicoli S, Tranfo G. 2016. Biomarkers of susceptibility following benzene exposure: influence of genetic polymorphisms on benzene metabolism and health effects. Biomark Med. 10:145–163.
   PubMed Web of Science ®Google Scholar
• Cox LA Jr. 1995. Simple relations between administered and internal doses in compartmental flow models. Risk Anal. 15:197–204.
   PubMed Web of Science ®Google Scholar
• Cox LA, Schnatter AR, Boogaard PJ, Banton M, Ketelslegers HB. 2017. Non-parametric estimation of low-concentration benzene metabolism. Chem Biol Interact. 278:242–255.
   PubMed Web of Science ®Google Scholar
• Cox LA Jr. 2018. Modernizing the Bradford Hill criteria for assessing causal relationships in observational data. Crit Rev Toxicol. 48:682–712.
   PubMed Web of Science ®Google Scholar
• Cox LAT Jr. 2019. Risk analysis implications of dose-response thresholds for NLRP3 inflammasome-mediated diseases: respirable crystalline silica and lung cancer as an example. Dose Response. 17:155932581983690.
   Web of Science ®Google Scholar
• Das M, Chaudhuri S, Law S. 2012. Benzene exposure – an experimental machinery for induction of myelodysplastic syndrome: stem cell and stem cell niche analysis in the bone marrow. J Stem Cells. 7:43–59.
   PubMedGoogle Scholar
• Du X, Jiang S, Zeng X, Zhang J, Pan K, Song L, Zhou J, Kan H, Sun Q, Zhao J, et al. 2019. Fine particulate matter-induced cardiovascular injury is associated with NLRP3 inflammasome activation in Apo E-/- mice. Ecotoxicol Environ Saf. 174:92–99.
   PubMed Web of Science ®Google Scholar
• Friedman JH. 2001. Greedy function approximation: a gradient boosting machine. Ann Statist. 29:1189–1232.
   Web of Science ®Google Scholar
• Fustinoni S, Campo L, Mercadante R, Consonni D, Mielzynska D, Bertazzi PA. 2011. A quantitative approach to evaluate urinary benzene and S-phenylmercapturic acid as biomarkers of low benzene exposure. Biomarkers. 16:334–345.
   PubMed Web of Science ®Google Scholar
• Galbraith D, Gross SA, Paustenbach D. 2010. Benzene and human health: a historical review and appraisal of associations with various diseases. Crit Rev Toxicol. 40 Suppl 2:1–46.
   PubMed Web of Science ®Google Scholar
• Glass DC, Gray CN, Jolley DJ, Gibbons C, Sim MR, Fritschi L, Adams GG, Bisby JA, Manuell R. 2003. Leukemia risk associated with low-level benzene exposure. Epidemiology. 14:569–577.
   PubMed Web of Science ®Google Scholar
• Goldstein A, Kapelner A, Bleich J, Pitkin E, 2015. Peeking inside the black box: visualizing statistical learning with plots of individual conditional expectation. J Comput Graph Stat. 24:44–65.
   Web of Science ®Google Scholar
• Grigoryan H, Edmands WMB, Lan Q, Carlsson H, Vermeulen R, Zhang L, Yin SN, Li GL, Smith MT, Rothman N, et al. 2018. Adductomic signatures of benzene exposure provide insights into cancer induction. Carcinogenesis. 39:661–668.
   PubMed Web of Science ®Google Scholar
• Gross SA, Paustenbach DJ. 2018. Shanghai Health Study (2001–2009): what was learned about benzene health effects? Crit Rev Toxicol. 48:217–251.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhong W, Chen Y, Zhang W, Ren J, Gao A. 2019. Benzene metabolites trigger pyroptosis and contribute to haematotoxicity via TET2 directly regulating the Aim2/Casp1 pathway. EBioMedicine. 47:578–589.
   PubMed Web of Science ®Google Scholar
• Hack CE, Haber LT, Maier A, Shulte P, Fowler B, Lotz WG, Savage RE Jr. 2010. A Bayesian network model for biomarker-based dose response. Risk Anal. 30:1037–1051.
   PubMed Web of Science ®Google Scholar
• Hamling JS, Coombs KJ, Lee PN. 2019. Misclassification of smoking habits: an updated review of the literature. World J Meta-Anal. 7:31–50.
   Google Scholar
• Hirabayashi Y, Inoue T. 2010. Benzene-induced bone-marrow toxicity: a hematopoietic stem-cell-specific, aryl hydrocarbon receptor-mediated adverse effect. Chem Biol Interact. 184:252–258.
   PubMed Web of Science ®Google Scholar
• Hornung RW, Lanphear BP. 2014. The supralinear dose-response for environmental toxicants: a statistical artifact? Clin Toxicol (Phila). 52:88–90.
   PubMed Web of Science ®Google Scholar
• Kerzic PJ, Irons RD. 2017. Distribution of chromosome breakpoints in benzene-exposed and unexposed AML patients. Environ Toxicol Pharmacol. 55:212–216.
   PubMed Web of Science ®Google Scholar
• Knutsen JS, Kerger BD, Finley B, Paustenbach DJ. 2013. A calibrated human PBPK model for benzene inhalation with urinary bladder and bone marrow compartments. Risk Anal. 33:1237–1251.
   PubMed Web of Science ®Google Scholar
• Lanphear BP. 2017. Low-level toxicity of chemicals: no acceptable levels? PLoS Biol. 15:e2003066.
   PubMed Web of Science ®Google Scholar
• Lin LC, Chen WJ, Chiung YM, Shih TS, Liao PC. 2008. Association between GST genetic polymorphism and dose-related production of urinary benzene metabolite markers, trans, trans-muconic acid and S-phenylmercapturic acid. Cancer Epidemiol Biomarkers Prev. 17:1460–1469.
   PubMed Web of Science ®Google Scholar
• McHale CM, Zhang L, Smith MT. 2012. Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis. 33:240–252.
   PubMed Web of Science ®Google Scholar
• McNally K, Sams C, Loizou GD, Jones K. 2017. Evidence for non-linear metabolism at low benzene exposures? A reanalysis of data. Chem Biol Interact. 278:256–268.
   PubMed Web of Science ®Google Scholar
• Meek ME, Klaunig JE. 2010. Proposed mode of action of benzene-induced leukemia: Interpreting available data and identifying critical data gaps for risk assessment. Chem Biol Interact. 184:279–285.
   PubMed Web of Science ®Google Scholar
• Neumann HG. 2009. Risk assessment of chemical carcinogens and thresholds. Crit Rev Toxicol. 39:449–461.
   PubMed Web of Science ®Google Scholar
• Nourozi MA, Neghab M, Bazzaz JT, Nejat S, Mansoori Y, Shahtaheri SJ. 2018. Association between polymorphism of GSTP1, GSTT1, GSTM1 and CYP2E1 genes and susceptibility to benzene-induced hematotoxicity. Arch Toxicol. 92:1983–1990.
   PubMed Web of Science ®Google Scholar
• Price PS, Rey TD, Fontaine DD, Arnold SM. 2012. A reanalysis of the evidence for increased efficiency in benzene metabolism at airborne exposure levels below 3 p.p.m. Carcinogenesis. 33:2094–2099.
   PubMed Web of Science ®Google Scholar
• Qian S, Han Y, Shi Y, Xu W, Zhu Y, Jiang S, Chen Y, Yu Z, Zhang S, Yang Y, et al. 2019. Benzene induces haematotoxicity by promoting deacetylation and autophagy. J Cell Mol Med. 23:1022–1033.
   PubMed Web of Science ®Google Scholar
• Qu Q, Shore R, Li G, Jin X, Chen LC, Cohen B, Melikian AA, Eastmond D, Rappaport S, Li H, et al. Validation and evaluation of biomarkers in workers exposed to benzene in China. Res Rep Health Eff Inst. 2003;115:1–72.
   PubMedGoogle Scholar
• Rappaport SM, Kim S, Lan Q, Li G, Vermeulen R, Waidyanatha S, Zhang L, Yin S, Smith MT, Rothman N. 2010. Human benzene metabolism following occupational and environmental exposures. Chem Biol Interact. 184:189–195.
   PubMed Web of Science ®Google Scholar
• Rappaport SM, Kim S, Thomas R, Johnson BA, Bois FY, Kupper LL. 2013. Low-dose metabolism of benzene in humans: science and obfuscation. Carcinogenesis. 34:2–9.
   PubMed Web of Science ®Google Scholar
• Rappaport SM, Kim S, Lan Q, Vermeulen R, Waidyanatha S, Zhang L, Li G, Yin S, Hayes RB, Rothman N, et al. 2009. Evidence that humans metabolize benzene via two pathways. Environ Health Perspect. 117:946–952.
   PubMed Web of Science ®Google Scholar
• Rhomberg LR. 2009. Uptake kinetics, species differences, and the determination of equivalent combinations of air concentration and exposure duration for assessment of acute inhalation toxicity. Hum Ecol Risk Assess. 15:1099–1145.
   Web of Science ®Google Scholar
• Richardson DB. 2009. Multistage modeling of leukemia in benzene workers: a simple approach to fitting the 2-stage clonal expansion model. Am J Epidemiol. 169:78–85.
   PubMed Web of Science ®Google Scholar
• Rousseeuw PJ. 1987. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math. 20:53–65.
   Web of Science ®Google Scholar
• Rushton L, Schnatter AR, Tang G, Glass DC. 2014. Acute myeloid and chronic lymphoid leukaemias and exposure to low-level benzene among petroleum workers. Br J Cancer. 110:783–787.
   PubMed Web of Science ®Google Scholar
• Sallman DA, Cluzeau T, Basiorka AA, List A. 2016. Unraveling the pathogenesis of MDS: the NLRP3 inflammasome and pyroptosis drive the MDS phenotype. Front Oncol. 6:151.
   PubMed Web of Science ®Google Scholar
• Sallman DA, List A. 2019. The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. Blood. 133:1039–1048.
   PubMed Web of Science ®Google Scholar
• Schnatter AR, Glass DC, Tang G, Irons RD, Rushton L. 2012. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis. J Natl Cancer Inst. 104:1724–1737.
   PubMed Web of Science ®Google Scholar
• Slenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, Mélius J, Cirillo E, Coort SL, Digles D, et al. 2018. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res. 46:D661–D667.
   PubMed Web of Science ®Google Scholar
• Smith MT. 1996. Overview of benzene-induced aplastic anaemia. Eur J Haematol Suppl. 60:107–110.
   PubMedGoogle Scholar
• Snyder R. 2012. Leukemia and benzene. Int J Environ Res Public Health. 9:2875–2893.
   PubMed Web of Science ®Google Scholar
• Son MY, Deng CX, Hoeijmarkers JH, Rebel VI, Hasty P. 2016. A mechanism for 1,4-benzoquinone-induced genotoxicity. Oncotarget. 7:46433–46447.
   PubMedGoogle Scholar
• Teras LR, Diver WR, Deubler EL, Krewski D, Flowers CR, Switchenko JM, Gapstur SM. 2019. Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignancies. Int J Cancer. 145:2647–2660.
   PubMed Web of Science ®Google Scholar
• Titmarsh GJ, McMullin MF, McShane CM, Clarke M, Engels EA, Anderson LA. 2014. Community-acquired infections and their association with myeloid malignancies. Cancer Epidemiol. 38:56–61.
   PubMed Web of Science ®Google Scholar
• Tranfo G, Pigini D, Paci E, Bauleo L, Forastiere F, Ancona C. 2018. Biomonitoring of urinary benzene metabolite SPMA in the general population in central Italy. Toxics. 6:37.
   Web of Science ®Google Scholar
• Vlaanderen J, Portengen L, Rothman N, Lan Q, Kromhout H, Vermeulen R. 2010. Flexible meta-regression to assess the shape of the benzene-leukemia exposure-response curve. Environ Health Perspect. 118:526–532.
   PubMed Web of Science ®Google Scholar
• Waddell WJ. 2006. Critique of dose response in carcinogenesis. Hum Exp Toxicol. 25:413–436.
   PubMed Web of Science ®Google Scholar
• Wang L, He X, Bi Y, Ma Q. 2012. Stem cell and benzene-induced malignancy and hematotoxicity. Chem Res Toxicol. 25:1303–1315.
   PubMed Web of Science ®Google Scholar
• Weisel CP. 2010. Benzene exposure: an overview of monitoring methods and their findings. Chem Biol Interact. 184:58–66.
   PubMed Web of Science ®Google Scholar
• Wei J, Wang H, Wang H, Wang B, Meng L, Xin Y, Jiang X. 2019. The role of NLRP3 inflammasome activation in radiation damage. Biomed Pharmacother. 118:109217.
   PubMed Web of Science ®Google Scholar
• Yokley K, Tran HT, Pekari K, Rappaport S, Riihimaki V, Rothman N, Waidyanatha S, Schlosser PM. 2006. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach. Risk Anal. 26:925–943.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Kwak WS, Ahn YS. 2018. A brief review of relationship between occupational benzene exposure and hematopoietic cancer. Ann Occup Environ Med. 30:33.
   PubMed Web of Science ®Google Scholar